Pulmonary clearance of vasoactive intestinal peptide.
Vasoactive intestinal peptide causes bronchodilatation when given intravenously but is less effective in both animals and man when given by inhalation. This difference may be due to poor transit of the peptide across the bronchial epithelium. To test this hypothesis pulmonary clearance of radiolabel...
Uloženo v:
| Vydáno v: | Thorax |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMJ Publishing Group
1986
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC460268/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3010486/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.41.2.88 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
